IPG Photonics

IPGP

Market cap $3.64B

nLIGHT's defense-driven surge and 173% YTD gain outshine IPG Photonics, making LASR the stronger fiber laser stock pick now.

MARLBOROUGH, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- IPG Photonics, the global leader in fiber laser technology, proudly announces the first public display of the CROSSBOW™ MINI 3 kW high-energy laser (HEL) system at Defence and Security Equipment International (DSEI) UK from September 9th through 12th, 2025. IPG CROSSBOW MINI is a patent-pending, compact field-ready laser defense system engineered to counter the escalating threat of unmanned aerial systems (UAS). Designed for immediate deployment and scalable integration, CROSSBOW marks a transformative leap in directed-energy defense.

Explore how IPG's (IPGP) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

IPG Photonics (IPGP) Q2 Revenue Up 9%

IPG Photonics (IPGP -3.77%) reported Q2 2025 revenue of $251 million, up 10% sequentially and representing its first year-over-year increase (excluding divestitures) since 2022. Adjusted gross margin reached 37.8% in Q2 2025, at the top of guidance, supported by operational improvements and cost controls, while adjusted earnings per diluted share of $0.30 exceeded management's guided range.

IPGP's second-quarter 2025 results reflect lower revenues from the Materials processing segment.

IPG Photonics Corporation (NASDAQ:IPGP ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Eugene Fedotoff - Senior Director of Investor Relations Mark Milton Gitin - CEO & Director Timothy P. V. Mammen - Senior VP & CFO Conference Call Participants James Andrew Ricchiuti - Needham & Company, LLC, Research Division Mark S.

Image source: The Motley Fool.

IPG Photonics (IPGP) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.45 per share a year ago.

IPG Photonics' second-quarter 2025 results are likely to benefit from improving Welding and medical markets amid tariff-related headwinds.